Taysha Gene Therapies, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Taysha Gene Therapies, Inc. | TSHA - NASDAQ |
$18.00-$20.00 | $20.00 | $22.25 | 7.9 million | 9/24/2020 |
| Goldman Sachs, Morgan Stanley, Jefferies | ||||||
Co-Manager(s): Chardan | ||||||
| Health Care | ||||||
Filing(s): Filed 2020-09-02 Terms Added 2020-09-17 | ||||||
Taysha Gene Therapies, Inc. Quote & Chart - Click for current quote - TSHA
IPO Boutique aggregates information on public companies and private companies, such as "TSHA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Taysha Gene Therapies, Inc. (adapted from Taysha Gene Therapies, Inc. prospectus):
They are a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "TSHA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.